NO306700B1 - Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister - Google Patents

Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister

Info

Publication number: NO306700B1
Authority: NO; Norway
Prior art keywords: pct; rectal administration; alkylsulfonamides; agonists; pharmaceuticals
Prior art date: 1992-05-07

Application number

NO944214A

Other languages

English (en)

Norwegian (no)

Other versions

NO944214L (no

NO944214D0 (no

Inventor

Nadine Merlet

Isabelle Richard

Isabelle Thielemans

Original Assignee

Glaxo Lab Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-07

Filing date

1994-11-04

Publication date

1999-12-13

1994-11-04 Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa

1994-11-04 Publication of NO944214D0 publication Critical patent/NO944214D0/no

1994-11-07 Publication of NO944214L publication Critical patent/NO944214L/no

1999-12-13 Publication of NO306700B1 publication Critical patent/NO306700B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Compositions Of Macromolecular Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

NO944214A 1992-05-07 1994-11-04 Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister NO306700B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB929209882A GB9209882D0 (en)	1992-05-07	1992-05-07	Compositions
PCT/EP1993/001077 WO1993021916A1 (en)	1992-05-07	1993-05-03	Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration

Publications (3)

Publication Number	Publication Date
NO944214D0 NO944214D0 (no)	1994-11-04
NO944214L NO944214L (no)	1994-11-07
NO306700B1 true NO306700B1 (no)	1999-12-13

Family

ID=10715158

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO944214A NO306700B1 (no)	1992-05-07	1994-11-04	Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister

Country Status (33)

Country	Link
US (1)	US5705506A (it)
EP (1)	EP0639072B1 (it)
JP (1)	JPH07506570A (it)
KR (1)	KR100253111B1 (it)
AT (1)	ATE163850T1 (it)
AU (1)	AU670083B2 (it)
BE (1)	BE1007024A5 (it)
BG (1)	BG62120B1 (it)
BR (1)	BR1100108A (it)
CA (1)	CA2135179C (it)
CH (1)	CH685920A5 (it)
CY (1)	CY2039B1 (it)
CZ (1)	CZ283512B6 (it)
DE (1)	DE69317418T2 (it)
ES (1)	ES2113533T3 (it)
FR (1)	FR2690847B1 (it)
GB (2)	GB9209882D0 (it)
GR (1)	GR3026584T3 (it)
HK (1)	HK95697A (it)
HU (2)	HU227338B1 (it)
IE (1)	IE75203B1 (it)
IL (1)	IL105468A (it)
IT (1)	IT1261471B (it)
NO (1)	NO306700B1 (it)
NZ (1)	NZ252132A (it)
OA (1)	OA10109A (it)
RO (1)	RO112993B1 (it)
RU (1)	RU2118527C1 (it)
SG (1)	SG46649A1 (it)
TW (1)	TW231970B (it)
UA (1)	UA37206C2 (it)
WO (1)	WO1993021916A1 (it)
ZA (1)	ZA933178B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2434297A (en) *	1996-05-23	1997-12-09	Alcon Laboratories, Inc.	The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en)	1997-11-06	2007-03-13	Cady Roger K	Preemptive prophylaxis of migraine
TR200002771T2 (tr) *	1998-03-26	2001-02-21	Fujisawa Pharmaceutical Co.,Ltd.	Devamlı salımı olan preparatlar
AU3731400A (en) *	1999-03-05	2000-09-21	Trustees Of University Technology Corporation, The	Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) *	2005-10-14	2007-10-17	Athersys Inc	Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
SI2124556T1 (sl)	2006-10-09	2015-01-30	Charleston Laboratories, Inc.	Farmacevtske sestave
JP5714910B2 (ja)	2008-01-09	2015-05-07	チャールストンラボラトリーズ，インコーポレイテッド	薬学的組成物
WO2011006012A1 (en)	2009-07-08	2011-01-13	Charleston Laboratories Inc.	Pharmaceutical compositions
US9186359B2 (en)	2010-10-15	2015-11-17	Contera Pharma Aps	Combinations of serotonin receptor agonists for treatment of movement disorders
SG11201406690SA (en)	2012-04-18	2014-11-27	Contera Pharma Aps	Orally available pharmaceutical formulation suitable for improved management of movement disorders
WO2017152130A1 (en)	2016-03-04	2017-09-08	Charleston Laboratories, Inc.	Pharmaceutical compositions
WO2018011181A1 (en)	2016-07-11	2018-01-18	Contera Pharma Aps	Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2082175B (en) *	1980-08-12	1984-05-02	Glaxo Group Ltd	Heterocyclic compounds
GB2083463B (en) *	1980-08-12	1984-05-10	Glaxo Group Ltd	Heterocyclic compounds
ZW19381A1 (en) *	1980-08-12	1983-03-09	Glaxo Group Ltd	Heterocyclic compounds
IT1170387B (it) *	1982-06-07	1987-06-03	Glaxo Group Ltd	Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332435D0 (en) *	1983-12-06	1984-01-11	Glaxo Group Ltd	Chemical compounds
GB2162522B (en) *	1984-08-01	1988-02-24	Glaxo Group Ltd	An indole derivative
GB8419575D0 (en) *	1984-08-01	1984-09-05	Glaxo Group Ltd	Chemical compounds
FR2574077A1 (fr) *	1984-12-04	1986-06-06	Glaxo Group Ltd	Derives d'indoles, leur preparation et les compositions pharmaceutiques les contenant
GB8431426D0 (en) *	1984-12-13	1985-01-23	Glaxo Group Ltd	Chemical compounds
DE3678805D1 (de) *	1985-11-08	1991-05-23	Glaxo Group Ltd	Indolderivate.
KR0131327B1 (en) *	1987-08-13	1998-04-17	Glaxo Group Ltd	Indole derivatives
MC2210A1 (fr) *	1990-06-07	1992-11-26	Wellcome Found	Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer

1992
- 1992-05-07 GB GB929209882A patent/GB9209882D0/en active Pending
1993
- 1993-04-20 IL IL10546893A patent/IL105468A/en not_active IP Right Cessation
- 1993-05-03 HU HU9403188A patent/HU227338B1/hu unknown
- 1993-05-03 EP EP93909884A patent/EP0639072B1/en not_active Expired - Lifetime
- 1993-05-03 DE DE69317418T patent/DE69317418T2/de not_active Expired - Lifetime
- 1993-05-03 CA CA002135179A patent/CA2135179C/en not_active Expired - Fee Related
- 1993-05-03 US US08/331,485 patent/US5705506A/en not_active Expired - Fee Related
- 1993-05-03 JP JP5518928A patent/JPH07506570A/ja active Pending
- 1993-05-03 ES ES93909884T patent/ES2113533T3/es not_active Expired - Lifetime
- 1993-05-03 AT AT93909884T patent/ATE163850T1/de active
- 1993-05-03 UA UA94115989A patent/UA37206C2/uk unknown
- 1993-05-03 NZ NZ252132A patent/NZ252132A/en not_active IP Right Cessation
- 1993-05-03 WO PCT/EP1993/001077 patent/WO1993021916A1/en not_active Ceased
- 1993-05-03 RO RO94-01790A patent/RO112993B1/ro unknown
- 1993-05-03 AU AU40640/93A patent/AU670083B2/en not_active Ceased
- 1993-05-03 CZ CZ942723A patent/CZ283512B6/cs not_active IP Right Cessation
- 1993-05-03 RU RU94046069/14A patent/RU2118527C1/ru not_active IP Right Cessation
- 1993-05-05 SG SG1996007136A patent/SG46649A1/en unknown
- 1993-05-05 GB GB9309209A patent/GB2266665B/en not_active Expired - Lifetime
- 1993-05-06 IE IE930339A patent/IE75203B1/en not_active IP Right Cessation
- 1993-05-06 ZA ZA933178A patent/ZA933178B/xx unknown
- 1993-05-06 CH CH139793A patent/CH685920A5/fr not_active IP Right Cessation
- 1993-05-06 BE BE9300467A patent/BE1007024A5/fr not_active IP Right Cessation
- 1993-05-06 IT ITRM930286A patent/IT1261471B/it active IP Right Grant
- 1993-05-06 FR FR9305432A patent/FR2690847B1/fr not_active Expired - Lifetime
- 1993-05-12 TW TW082103742A patent/TW231970B/zh active
1994
- 1994-11-04 NO NO944214A patent/NO306700B1/no not_active IP Right Cessation
- 1994-11-04 OA OA60578A patent/OA10109A/en unknown
- 1994-11-05 KR KR1019940703950A patent/KR100253111B1/ko not_active Expired - Fee Related
- 1994-11-07 BG BG99167A patent/BG62120B1/bg unknown
1995
- 1995-06-29 HU HU95P/P00531P patent/HU211638A9/hu unknown
1996
- 1996-12-24 BR BR1100108-9A patent/BR1100108A/pt active IP Right Grant
1997
- 1997-06-26 HK HK95697A patent/HK95697A/xx not_active IP Right Cessation
1998
- 1998-04-10 GR GR980400773T patent/GR3026584T3/el unknown
- 1998-04-30 CY CY9802039A patent/CY2039B1/xx unknown

Also Published As

Publication number	Publication date
OA10109A (en)	1996-12-18
EP0639072A1 (en)	1995-02-22
ITRM930286A0 (it)	1993-05-06
NO944214L (no)	1994-11-07
DE69317418D1 (de)	1998-04-16
GB9209882D0 (en)	1992-06-24
NO944214D0 (no)	1994-11-04
RU2118527C1 (ru)	1998-09-10
BR1100108A (pt)	1999-12-07
US5705506A (en)	1998-01-06
GR3026584T3 (en)	1998-07-31
HUT71418A (en)	1995-11-28
ATE163850T1 (de)	1998-03-15
SG46649A1 (en)	1998-02-20
BG99167A (bg)	1995-06-30
CZ283512B6 (cs)	1998-04-15
UA37206C2 (uk)	2001-05-15
DE69317418T2 (de)	1998-07-30
KR100253111B1 (en)	2000-07-01
BE1007024A5 (fr)	1995-02-21
ES2113533T3 (es)	1998-05-01
TW231970B (it)	1994-10-11
IT1261471B (it)	1996-05-23
IL105468A (en)	1998-09-24
GB2266665B (en)	1996-05-22
ZA933178B (en)	1994-01-10
WO1993021916A1 (en)	1993-11-11
EP0639072B1 (en)	1998-03-11
GB2266665A (en)	1993-11-10
CA2135179C (en)	2000-12-05
HU227338B1 (en)	2011-04-28
AU670083B2 (en)	1996-07-04
AU4064093A (en)	1993-11-29
CZ272394A3 (en)	1995-10-18
ITRM930286A1 (it)	1994-11-06
CH685920A5 (fr)	1995-11-15
NZ252132A (en)	1996-09-25
GB9309209D0 (en)	1993-06-16
FR2690847B1 (fr)	1995-06-09
JPH07506570A (ja)	1995-07-20
HK95697A (en)	1997-08-08
IE75203B1 (en)	1997-08-27
BG62120B1 (bg)	1999-03-31
CY2039B1 (en)	1998-04-30
IL105468A0 (en)	1993-08-18
FR2690847A1 (fr)	1993-11-12
RO112993B1 (ro)	1998-03-30
IE930339A1 (en)	1993-11-17
HU211638A9 (en)	1995-12-28
CA2135179A1 (en)	1993-11-11

Publication	Publication Date	Title
ATE331726T1 (de)	2006-07-15	Adenine-derivate
DK0641328T3 (da)	2002-05-21	Broforbundne, azabicykliske derivater som substans P-antagonister
MX9301032A (es)	1993-09-01	Compuestos farmaceuticos y procedimento para su preparacion
BR9912975A (pt)	2001-09-25	Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
MX9702865A (es)	1998-05-31	Agentes estrogenicos.
NO306700B1 (no)	1999-12-13	Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister
KR890700125A (ko)	1989-03-02	신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
NO20061737L (no)	2006-05-31	Aminosubstituerte erylamino B2 adrenergiske receptoragonister
ES2147758T3 (es)	2000-10-01	Preparacion sinergistica para la activacion de celulas destructoras naturales.
ZA971279B (en)	1998-08-14	Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
BR9910329A (pt)	2001-01-30	Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
DK0623121T3 (da)	1998-10-07	Fremstilling af N-acetylneuraminsyrederivater
SE9702002D0 (sv)	1997-05-28	Novel compounds
TNSN98049A1 (fr)	2005-03-15	Composition pharmaceutique a residence gastrique.
NO995685D0 (no)	1999-11-19	Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasöytiske blandinger
FI950209A0 (fi)	1995-01-18	Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
ATE141248T1 (de)	1996-08-15	Neue bis-phenyl-hexene
ECSP972347A (es)	1998-12-14	Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
ECSP972049A (es)	1998-02-13	Derivados de lactama

Legal Events

Date	Code	Title	Description
2013-05-21	MK1K	Patent expired